Skip to content

DAXISPHARMA

Inactive
Public limited companyKBO/BCE: BE 0420.720.276

Inactive since 14-10-2026; last annual accounts for financial year 2025.

DAXISPHARMAInactive

Overview

Activity
“Toutes activités de nature civile, commerciale, financière, administrative, industrielle ou technique, en relation directe…” (deed in French)
From the articles, 4 activitiesNo NACE code in the KBO yet
Size
≈ €12.0mturnover 2025, estimated
Staff
43.9 FTE
Equity
€6.0m
Profit
€166,396
Turnover estimated from the gross margin
Financial health
Inactive: no score
Structure
Parent
Servier Benelux · 100%
Board
6 members
Auditor: EY Réviseurs d'Entreprises SRL9 of 29 deeds summarised
SignalsneutralLatest accounts filed on timeShow the evidence

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 10-03-2026, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
51 days early
2024
34 days early
2023
15 days early
2022
22 days late
2021
2 days early
2020
30 days early
2019
61 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 7 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 16 April (4 of the last 5 filed years within 36 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end30-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. General meeting · DeclarationMerger · Share cancellation ·…
  2. RestructuringMerger · Shareholding · Board…
  3. Reappointments: Ziad Matta, Stéphane Mascarau and…Power of attorney

Financials · financial year 2025, full format

Turnover
≈ €12.0m
Estimated: probably between €8.2m and €20.0m
EBIT margin
Not included in this filing
Net result
€166,396▼ 18.7%
2024 · €204,594
Working capital
€5.9m▲ 12.1%
2024 · €5.3m
Trend over the years

2021 to 2025, 5 financial years 2021 to 2025, 5 financial years

The operating result recovers in 2025; 2025 is 5% above 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.3m 2025 Net result€0.2m 2025

Use the arrow keys on the chart for the figures per year.

Every figure with its change against the financial year before
favourable unfavourable
Line20212022202320242025
Operating result€0.3m-€0.2m▼ 27.5%€0.3m▲ 43.4%€0.2m▼ 22.6%€0.3m▲ 5.0%
Net result€0.1m-€0.05m▼ 63.0%€0.2m▲ 370%€0.2m▼ 7.2%€0.2m▼ 18.7%
Equity€6.3m€6.5m▲ 3.5%€6.1m▼ 6.1%€6.0m▼ 2.2%
Total assets€19.0m-€17.3m▼ 9.0%€14.2m▼ 18.2%€15.8m▲ 11.2%€25.2m▲ 59.9%
Debt€12.8m-€11.0m▼ 13.7%€7.7m▼ 30.5%€9.7m▲ 25.8%€19.2m▲ 99.3%
Working capital€5.2m-€5.3m▲ 2.3%€5.6m▲ 5.3%€5.3m▼ 5.7%€5.9m▲ 12.1%
Staff (FTE)41-40▼ 2.4%41.7▲ 4.3%44.1▲ 5.8%43.9▼ 0.5%
The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €25.2m
Fixed assets €96,521 ▼ 88.9%
Current assets €25.1m ▲ 68.6%
Equity and liabilities €25.2m
Equity €6.0m ▼ 2.2%
Debt €19.2m ▲ 99.3%
Debt's share of the balance-sheet total rises from 61.2% to 76.3%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€355,008▲
2024 · €352,072
Cash flow
€267,117▼
2024 · €314,382
Current ratio
1.31▼
2024 · 1.54
Quick ratio
1.27▼
2024 · 1.54
Debt to equity
3.21▲
2024 · 1.58
ROE
2.8%▼
2024 · 3.3%
ROA
0.7%▼
2024 · 1.3%
Interest coverage
1.09▼
2024 · 1.36
Debt ≤ 1 year
€19.2m▲
2024 · €9.7m
Income taxes
€185,239▲
2024 · €181,400
Staff costs
€6.6m▲
2024 · €6.3m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 58 lines
Balance sheet Code20242025
Assets
Total assets20/58€15.8m€25.2m▲
Fixed assets21/28€0.9m€0.1m▼
Intangible fixed assets21€0-
Tangible fixed assets22/27€0.9m€0.1m▼
Land and buildings22€0.8m-
Plant, machinery and equipment23€0.02m-
Furniture and vehicles24€0.05m€0.09m▲
Other tangible fixed assets26-€0.006m
Current assets29/58€14.9m€25.1m▲
Stocks and contracts in progress3-€0.8m
Stocks30/36-€0.8m
Amounts receivable within one year40/41€2.6m€1.6m▼
Trade receivables40€291€1.6m▲
Other amounts receivable41€2.6m€0.02m▼
Current investments50/53€10.6m€22.5m▲
Cash at bank and in hand54/58€1.7m€0.1m▼
Deferred charges and accrued income490/1€0.04m€0.04m▲
Equity and liabilities
Total equity and liabilities10/49€15.8m€25.2m▲
Equity10/15€6.1m€6.0m▼
Contributions10/11€5.6m€5.6m=
Capital10€5.6m€5.6m=
Issued capital100€5.6m€5.6m=
Reserves13€0.3m€0.3m▲
Non-distributable reserves130/1€0.3m€0.3m▲
Legal reserve130€0.3m€0.3m▲
Profit (loss) carried forward14€0.2m€0.08m▼
Amounts payable17/49€9.7m€19.2m▲
Amounts payable within one year42/48€9.7m€19.2m▲
Financial debts43€7.2m€16.7m▲
Other loans439€7.2m€16.7m▲
Trade debts44€0.2m€0.2m▼
Suppliers440/4€0.2m€0.2m▼
Taxes, remuneration and social security45€1.4m€1.8m▲
Taxes450/3€0.2m€0.6m▲
Remuneration and social security454/9€1.2m€1.2m▲
Other amounts payable47/48€0.8m€0.6m▼
Income statement Code20242025
Non-recurring operating income76A-€290
Goods, raw materials, services and sundry goods60/61€1.5m-
Remuneration, social security and pensions62€6.3m€6.6m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.1m€0.1m▼
Other operating charges640/8€0.2m€0.1m▼
Gross operating margin9900€6.9m€7.1m▲
Operating profit (loss)9901€0.2m€0.3m▲
Financial income75/76B€0.4m€0.4m▲
Recurring financial income75€0.4m€0.4m▲
Financial charges65/66B€0.3m€0.3m▲
Recurring financial charges65€0.3m€0.3m▲
Profit (loss) for the period before taxes9903€0.4m€0.4m▼
Income taxes67/77€0.2m€0.2m▲
Profit (loss) for the period9904€0.2m€0.2m▼
Profit (loss) for the period to be appropriated9905€0.2m€0.2m▼
Appropriation of the result
Profit (loss) to be appropriated9906€0.8m€0.4m▼
Profit (loss) brought forward from the previous period14P€0.6m€0.2m▼
Transfer to equity691/2€0.01m€0.008m▼
To the legal reserve6920€0.01m€0.008m▼
Profit to be distributed694/7€0.6m€0.3m▼
Return on contributions (dividend)694€0.6m€0.3m▼
Social balance sheet
Average headcount (FTE)908744.143.9▼

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A€0.07m€0.02m--€290-
Goods, raw materials, services and sundry goods60/61--€1.6m€1.5m--
Remuneration, social security and pensions62€4.9m€5.0m€5.4m€6.3m€6.6m▲ 3.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.2m€0.2m€0.1m€0.1m€0.1m▼ 8.3%
Other operating charges640/8€0.1m€0.1m€0.1m€0.2m€0.1m▼ 9.5%
Gross operating margin9900€5.6m€5.5m€6.0m€6.9m€7.1m▲ 3.1%
Operating profit (loss)9901€0.3m€0.2m€0.3m€0.2m€0.3m▲ 5.0%
Financial income75/76B-€0.003m€0.3m€0.4m€0.4m▲ 5.2%
Recurring financial income75-€0.003m€0.3m€0.4m€0.4m▲ 5.2%
Financial charges65/66B€0.04m€0.04m€0.2m€0.3m€0.3m▲ 26.0%
Recurring financial charges65€0.04m€0.04m€0.2m€0.3m€0.3m▲ 26.0%
Profit (loss) for the period before taxes9903€0.3m€0.2m€0.4m€0.4m€0.4m▼ 8.9%
Income taxes67/77€0.1m€0.1m€0.2m€0.2m€0.2m▲ 2.1%
Profit (loss) for the period9904€0.1m€0.05m€0.2m€0.2m€0.2m▼ 18.7%
Profit (loss) for the period to be appropriated9905€0.1m€0.05m€0.2m€0.2m€0.2m▼ 18.7%
Line20212022202320242025Change
Assets
Total assets20/58€19.0m€17.3m€14.2m€15.8m€25.2m▲ 59.9%
Fixed assets21/28€1.1m€1.0m€0.9m€0.9m€0.1m▼ 88.9%
Intangible fixed assets21-€0.003m€0.001m€0--
Tangible fixed assets22/27€1.1m€1.0m€0.9m€0.9m€0.1m▼ 88.9%
Land and buildings22€1.0m€0.9m€0.9m€0.8m--
Plant, machinery and equipment23€0.1m€0.02m€0.02m€0.02m--
Furniture and vehicles24€0.02m€0.05m€0.05m€0.05m€0.09m▲ 100.0%
Other tangible fixed assets26----€0.006m-
Assets under construction and advance payments27€0.01m€0.004m€0.004m---
Financial fixed assets28€0.001m-----
Current assets29/58€18.0m€16.3m€13.2m€14.9m€25.1m▲ 68.6%
Stocks and contracts in progress3----€0.8m-
Stocks30/36----€0.8m-
Amounts receivable within one year40/41€1.8m€1.3m€2.0m€2.6m€1.6m▼ 37.0%
Trade receivables40€0.07m€0.09m€0.05m€291€1.6m▲ 5,591×
Other amounts receivable41€1.8m€1.2m€1.9m€2.6m€0.02m▼ 99.3%
Current investments50/53€9.3m€8.8m€11.0m€10.6m€22.5m▲ 112%
Cash at bank and in hand54/58€6.8m€6.3m€0.3m€1.7m€0.1m▼ 90.9%
Deferred charges and accrued income490/1€0.04m€0.03m€0.02m€0.04m€0.04m▲ 7.4%
Equity and liabilities
Total equity and liabilities10/49€19.0m€17.3m€14.2m€15.8m€25.2m▲ 59.9%
Equity10/15-€6.3m€6.5m€6.1m€6.0m▼ 2.2%
Contributions10/11€5.6m€5.6m€5.6m€5.6m€5.6m=
Capital10€5.6m€5.6m€5.6m€5.6m€5.6m=
Issued capital100€5.6m€5.6m€5.6m€5.6m€5.6m=
Reserves13€0.3m€0.3m€0.3m€0.3m€0.3m▲ 2.9%
Non-distributable reserves130/1€0.3m€0.3m€0.3m€0.3m€0.3m▲ 2.9%
Legal reserve130€0.3m€0.3m€0.3m€0.3m€0.3m▲ 2.9%
Profit (loss) carried forward14€0.4m€0.4m€0.6m€0.2m€0.08m▼ 64.9%
Amounts payable17/49€12.8m€11.0m€7.7m€9.7m€19.2m▲ 99.3%
Amounts payable within one year42/48€12.8m€11.0m€7.7m€9.7m€19.2m▲ 99.3%
Financial debts43€10.7m€9.4m€5.9m€7.2m€16.7m▲ 132%
Other loans439€10.7m€9.4m€5.9m€7.2m€16.7m▲ 132%
Trade debts44€0.9m€0.4m€0.5m€0.2m€0.2m▼ 18.5%
Suppliers440/4€0.9m€0.4m€0.5m€0.2m€0.2m▼ 18.5%
Taxes, remuneration and social security45€1.2m€1.2m€1.1m€1.4m€1.8m▲ 26.6%
Taxes450/3€0.2m€0.2m€0.2m€0.2m€0.6m▲ 168%
Remuneration and social security454/9€1.0m€1.1m€1.0m€1.2m€1.2m▲ 1.9%
Other amounts payable47/48--€0.2m€0.8m€0.6m▼ 27.5%
Accrued charges and deferred income492/3€0.006m-----
Line20212022202320242025Change
Profit (loss) for the period9904€0.1m€0.05m€0.2m€0.2m€0.2m▼ 18.7%
+ Depreciation and write-downs630€0.2m€0.2m€0.1m€0.1m€0.1m▼ 8.3%
Operating cash flow (approximation)€0.3m€0.2m€0.4m€0.3m€0.3m▼ 15.0%
Investment in fixed assets (approximation)--€0.09m-€0.08m-€0.03m€0.7m-
Change in cash--€0.5m-€6.0m€1.4m-€1.5m-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 45 filings with the National Bank
Financial year Type Filed Reference
30-09-2025 full format 10-03-2026 2026-00051756
30-09-2024 full format 27-03-2025 2025-00056028
30-09-2023 full format 15-04-2024 2024-00063699
30-09-2022 full format 22-05-2023 2023-00090866
30-09-2021 full format 28-04-2022 2022-20017389
30-09-2020 full format 31-03-2021 2021-09300439
30-09-2019 full format 30-06-2020 2020-24100237
30-09-2018 full format 25-04-2019 2019-10800346
30-09-2017 full format 16-04-2018 2018-10000184
30-09-2016 full format 16-05-2017 2017-12200555

Show all 45 filings

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
6 directors, 2 in day-to-day management, last change in 2026

Board 6

StéphaneMascarau
Director · since 30-05-2023
Current
François Albert Vilette
Director · since 28-03-2024
Current
Ziad MATTA
Director · since 11-06-2024
Current
Stéphane Mascarau
Director · since 04-03-2026
Current
Current
Current

Day-to-day management 2

Ziad MATTA
Managing director · since 04-03-2026
Current
PierreBOYER
Managing director
Current

Statutory auditor 1

EY Réviseurs d'Entreprises SRL
Statutory auditor · since 07-05-2025 · permanent representative: Thomas Meurice
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
20 of this company's 29 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

10 people since 2023, 8 in office
Show
  • Board
  • Day-to-day management
  • Statutory auditor
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
PhilipVanMuylders
  • Director, since before 30-05-2023
StéphaneMascarau
  • Director, from 30-05-2023 to date
François Albert Vilette
  • Director, from 28-03-2024 to date
Stéphane MASCAREAU
  • Director, since before 11-06-2024
Ziad MATTA
  • Director, from 11-06-2024 to date
  • Managing director, since before 07-05-2025
Stéphane Mascarau
  • Director, since before 07-05-2025
PierreBOYER
  • Managing director, since before 30-05-2023
EY Réviseurs d'Entreprises SRL
  • Statutory auditor, from 07-05-2025 to date
Pierre BOYER
  • Director, until 11-06-2024
Philip Van Muylders
  • Director, until 06-11-2023
See the board, name and registered office on a given date →

Owners and capital

Owners

6 owners

Chain of control

  1. SERVIER SASFR consolidates
  2. Servier Benelux 100%
  3. DAXISPHARMA

Highest known parent: SERVIER SAS (France). The sources do not say who stands above it.

According to the annual accounts to 30-09-2025 of DAXISPHARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Capital and shareholders

Shareholders according to the deeds
Stated in the act act of 03-08-2026 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Group and network

Connections & network

6 current directors
Depth

The board mandates are listed below; here you explore them as a network.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Acquisitions and mergers

1 transaction
Taken over by:SERVIER BENELUX
BE 0408.056.927operation treated as a merger by absorption · Gazette deed of 20-10-2026 (6 acts) · effective 01-10-2026

History

In 2026 the registered office moved to Bruxelles.1 DAXISPHARMA has filed 45 sets of annual accounts, the latest for financial year 2025.2 In 2026 the company was absorbed by merger into SERVIER BENELUX.3

  1. 1Belgian Official Gazette, 24-03-2026
  2. 2National Bank, annual accounts 2025
  3. 3Belgian Official Gazette, 20-10-2026

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 30-04-2027
2026
20-10
Gazette deed General meeting · Declaration
Merger · Share cancellation · Purpose change12 facts ▸
  • General meeting, 01-10-2026
  • Declaration, renonciation à l'état comptable intermédiaire, article 12:51, §2, dernier alinéa du Code des sociétés et des associations
  • Merger, opération assimilée à une fusion par absorption, décision correspondante de fusion par l'assemblée générale extraordinaire de la société absorbante
  • Declaration, aucune action émise, société absorbante est l'unique actionnaire de la société absorbée
  • Share cancellation, annulation du registre des actions
  • Purpose change
  • Declaration, actif transféré, ni immeubles, ni droits réels quelconques
  • Declaration, fonds de commerce, quitte et libre de toutes inscriptions, mentions marginales et transcriptions
  • Board meeting, exécution des résolutions prises, conseil d'administration de la société absorbante
  • Power of attorney, Coralie TILLEUX
  • Power of attorney, Thomas SION
  • Power of attorney
03-08
Gazette deed Restructuring
Merger · Shareholding · Board composition22 facts ▸
  • Merger, “fusion simplifiée, intégralité du patrimoine, tant activement que passivement” (deed in French)
  • Shareholding, Servier Benelux, SA (3 times)
  • Board composition, Ziad MATTA (managing director) (3 times)
  • Board composition, SERVIER NEDERLAND B.V. (director)
  • Board composition, ARTS ET TECHNIQUES DU PROGRES, SAS (director)
  • Board composition, François VILETTE (director) (2 times)
  • Board composition, Stéphane MASCARAU (director)
  • Purpose change (2 times)
  • Board composition, Claude BERTRAND (managing director) (2 times)
  • Board composition, Philippe GONNARD (director) (4 times)
  • Declaration, “droits spéciaux et titres, Aucun actionnaire et aucun titulaire de titres autres que des actions ne jouit de droits spéciaux. Aucun titre, part ou action, et au…” (deed in French)
  • Declaration, “avantages particuliers, Aucun avantage particulier ne sera octroyé aux membres des organes d'administration respectifs des sociétés appelées à fusionner.” (deed in French)
  • +10 further facts in this act
10-06
Gazette deed Reappointments: Ziad Matta, Stéphane Mascarau and François Vilette
Power of attorney7 facts ▸
  • General meeting, 04-03-2026
  • Power of attorney, Coralie-Anne Tilleux
  • Power of attorney, Luus Hillen
  • Power of attorney, ebl redsky
  • Director reappointment, Ziad Matta (managing director)
  • Director reappointment, Stéphane Mascarau (director)
  • Director reappointment, François Vilette (director)
24-03
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 03-02-2026
  • Registered-office move, Chaussée de Mons 1424,1070 Bruxelles (Anderlecht)
10-03
NBB filing Annual accounts filed
financial year 2025 · full format
2025
07-05
Gazette deed Reappointments: Ziad Matta, Stéphane Mascarau and 2 others
5 facts ▸
  • General meeting, 05-03-2025
  • Director reappointment, Ziad Matta (managing director)
  • Director reappointment, Stéphane Mascarau (director)
  • Director reappointment, François Vilette (director)
  • Auditor reappointment, EY Réviseurs d'Entreprises SRL (statutory auditor)
27-03
NBB filing Annual accounts filed
financial year 2024 · full format
2024
20-09
Gazette deed Permanent representative: Thomas Meurice
1 fact ▸
  • Permanent representative, Thomas Meurice (statutory auditor)
11-06
Gazette deed Reappointments: Stéphane MASCAREAU (director) and François VILETTE (director)
Resignation: Pierre BOYER (director) · Appointment: Ziad MATTA (director)7 facts ▸
  • General meeting, 27-03-2024
  • Director reappointment, Stéphane MASCAREAU (director)
  • Director reappointment, François VILETTE (director)
  • Director resignation, Pierre BOYER (director)
  • Director appointment, Ziad MATTA (director)
  • Board meeting, 27-03-2024
  • Other provision, “unanimité, administrateur-délégué” (deed in French)
15-04
NBB filing Annual accounts filed
financial year 2023 · full format
28-03
Gazette deed Resignation: Philip Van Muylders (director)
Appointment: François Albert Vilette (director) · Amendment of the articles · Director discharge5 facts ▸
  • General meeting, 06-11-2023
  • Amendment of the articles, “21,3,a,i” (deed in French)
  • Director resignation, Philip Van Muylders (director)
  • Director discharge, Philip Van Muylders (director)
  • Director appointment, François Albert Vilette (director)
2023
30-09
Financial Highest result from 2021 to 2025net €220,488 ▲370%
Operating result €313,038, net result €220,488, both a record.
Show earlier events
30-05
Gazette deed Reappointments: PierreBOYER (managing director) and PhilipVanMuylders (director)
Appointment: StéphaneMascarau (director) · Power of attorney14 facts ▸
  • Board meeting, 15-02-2023
  • Other provision, “retraitdepouvoirsdesignaturebancaire, datedelaprésente” (deed in French)
  • Power of attorney, PierreANDRIOT
  • Power of attorney, PascalLEMAIRE
  • Power of attorney, ThierryYVONNET
  • Power of attorney, PierreBOYER
  • Power of attorney, SébastienRENSON
  • Power of attorney, MartineTACQUET
  • General meeting, 01-03-2023
  • Other provision, “findesmandatsdesadministrateurs, àl'issuelaprésenteassemblée” (deed in French)
  • Director reappointment, PierreBOYER (managing director)
  • Director reappointment, PhilipVanMuylders (director)
  • +2 further facts in this act
22-05
NBB filing Annual accounts filed
financial year 2022 · full format · 22 days late
2022
30-09
Financial Weakest financial yearnet €46,885 ▼63%
Net result drops to €46,885, the lowest in the series.
28-04
NBB filing Annual accounts filed
financial year 2021 · full format
2021
31-03
NBB filing Annual accounts filed
financial year 2020 · full format
2020
30-06
NBB filing Annual accounts filed
financial year 2019 · full format · 61 days late
2019
25-04
NBB filing Annual accounts filed
financial year 2018 · full format
2018
16-04
NBB filing Annual accounts filed
financial year 2017 · full format
2017
16-05
NBB filing Annual accounts filed
financial year 2016 · full format · 16 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 45 annual accounts filed, the latest 10 are here; all 45 are under Financials.
9 of 29 deeds read
About the unread acts

Of the 29 Belgian Official Gazette deeds we know for this company, 9 have been read. The other 20 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.
Inactive

Absorbed by SERVIER BENELUX in October 2026

DAXISPHARMA is no longer in the KBO register: SERVIER BENELUX took it over in a merger by absorption, published in the Belgian Official Gazette on 20 October 2026.

Status
Inactiveout of the register since 14 October 2026
Reason
Merger by absorption"operation treated as a merger by absorption", Belgian Official Gazette, 20 October 2026 · act
Absorbed by
SERVIER BENELUX · 0408.056.927
Last annual accounts
financial year to 30 September 2025
Last registered office
Chaussee De Mons 1424, 1070 Anderlechtas published on 3 August 2026
Legal form
Public limited company
Active since
29 August 1980
Official KBO record

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Anderlecht
exact location from the address register On OpenStreetMap
Ground area
3.5 ha
Building footprint
6,370 m²
Building volume
161,344 m³
Parcel 21306D0005/00P000, Brussels · tallest building 32.2 m. Linked by address, not a title deed.
1 parcel
Brussels 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
21306D0005/00P000 Brussels 3.5 ha 1 · 6,370 m² 32.2 m · 9
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

PurposeThe activities the company may carry out under its articles.
“Toutes activités de nature civile, commerciale, financière, administrative, industrielle ou technique, en relation directe ou indirecte avec…” (deed in French)
4 activities (deed in French)
  1. Toutes activités de nature civile, commerciale, financière, administrative, industrielle ou technique, en relation directe ou indirecte avec la fabrication, le conditionnement, la distribution, la publicité et le commerce en général de tous produits pharmaceutiques, chimiques, cosmétiques, diététiques, vétérinaires et ménagers, tous dispositifs médicaux et tous articles et tout matériel servant à l'emballage et au conditionnement des produits cités, la publicité en général, le courtage et la coopération en matière de publicité
  2. L'exploitation directe ou indirecte de tous brevets, marques de fabrique, marques de commerce, procédés de fabrication et autres droits de propriété industrielle; l'acquisition, l'obtention, la cession ou la rétrocession, la licence ou la sous-licence, de tous brevets, marques, dénominations, procédés et autres droits; toutes recherches, études, améliorations et inventions en relation directe ou indirecte avec les objets précités
  3. Faire toutes acquisitions, négociations, ventes, échanges, dépôts, livraisons, expéditions, facturations et recouvrements, toutes opérations de commission, de mandat ou d'agence en général, ainsi que toutes opérations mobilières et immobilières en relation directe ou indirecte avec son objet ou de nature à faciliter, favoriser ou développer son commerce et son industrie
  4. Étendre son activité et acquérir des intérêts dans toutes entreprises industrielles, civiles ou commerciales, dont l'objet serait similaire ou en relation avec son propre objet ou dont la nature serait en mesure de faciliter, favoriser ou développer ses propres activités et même fusionner avec elles; elle peut leur apporter toute aide technique, commerciale ou financière et participer à leur gestion et administration; elle peut se constituer garant ou aval de tous engagements souscrits ou à souscrire par les sociétés ou entreprises dans lesquelles elle a un intérêt direct ou indirect

The full purpose is in the deed

deed of 03-08-2026
Other provisionsOther rules from the articles that fall under none of the themes above.
Accounting effect: 01-10-2026
Other provision: Condition suspensive, décision correspondante de fusion par l'assemblée générale extraordinaire de la société absorbante
deed of 20-10-2026

Read from the deeds: 3 provisions, deed of 20-10-2026